Related Experiment Video
Updated: Jul 11, 2025

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Meta-analysis of the Relationship between Type 2 Diabetes Mellitus and Renal Cancer Risk
Yingxin Wang1, Ying Cao1, Chenchen Zhu1
1Department of Ultrasound, The First Affiliated Hospital of Xinjiang Medical University, 830054, Xinjiang, People's Republic of China.
Objective:
This study aimed to investigate the relationship between type 2 diabetes mellitus and the risk of renal cancer.
Methods:
A search was carried out on PubMed, Embase, Web of Science, China Biology Medicine disc (CBM), China National Knowledge Infrastructure (CNKI), Wanfang and other databases. The search period was from 2000 to 2022. The two authors independently conducted literature screening, extracted literature data, and then conducted a literature quality evaluation. The type of study is a cohort study. Meta-analysis was carried out on the included literature through Stata12.0 software, and the combined value was calculated with RR value and 95% confidence interval. Subgroup analysis was carried out to explore the impact of different factors on the overall results.
Results:
A total of 10 articles were included. Through cohort study, the meta-analysis on the risk of type 2 diabetes and renal cancer showed that the combined effect value Risk Ratio (RR) = 1.57 with 95% Confidence Intervals (CI) (1.36, 1.82) and P<0.05. The difference had a significant impact, indicating that the risk of renal cancer in type 2 diabetes patients was 1.55 times higher than that in non-type 2 diabetes patients. The subgroup analysis showed that the combined effect value RR and 95% CI for men was 1.49 (1.26, 1.75), and the combined effect value RR and 95% CI for women was 1.60 (1.35, 1.88), which was basically consistent.
Conclusion:
Type 2 diabetes can significantly increase the risk of renal cell carcinoma, and the former is a risk factor for the latter. It is suggested that multi-center studies with larger sample sizes should be conducted in the future, and adjustments should be made according to the type of diabetes, the source of the study population, the pathological type of renal cell carcinoma, the use of hypoglycemic drugs, and other factors, to provide a reliable basis for the study of the relationship between diabetes and renal cell carcinoma. At present, the specific mechanism of diabetes increasing the risk of renal cell carcinoma and whether diabetes increases mortality due to renal cell carcinoma is still unclear and needs further research.
Insights
Type 2 diabetes significantly elevates the risk of developing renal cancer. This meta-analysis confirms that individuals with type 2 diabetes have a 1.55 times higher risk of renal cancer compared to those without the condition.
Area of Science:
- Nephrology
- Endocrinology
- Oncology
Background:
- Type 2 diabetes mellitus (T2DM) is a global health concern with numerous complications.
- Emerging evidence suggests a potential link between T2DM and increased cancer risk, including renal cancer.
- Understanding this association is crucial for patient management and public health strategies.
Purpose of the Study:
- To investigate the association between type 2 diabetes mellitus and the risk of renal cancer.
- To quantify the risk of renal cancer in patients with T2DM through a meta-analysis.
Main Methods:
- A comprehensive literature search was conducted across multiple databases (PubMed, Embase, Web of Science, CBM, CNKI, Wanfang) from 2000 to 2022.
- Included studies were cohort studies, independently screened and data extracted by two authors.
- Meta-analysis was performed using Stata 12.0, calculating Risk Ratios (RR) with 95% Confidence Intervals (CI), and subgroup analyses were conducted.
Main Results:
- Ten cohort studies were included in the meta-analysis.
- Type 2 diabetes was associated with a significantly increased risk of renal cancer (RR = 1.57, 95% CI: 1.36–1.82, P<0.05).
- The risk was consistently elevated in both men (RR = 1.49) and women (RR = 1.60), indicating T2DM is a risk factor for renal cancer.
Conclusions:
- Type 2 diabetes mellitus is a significant risk factor for developing renal cell carcinoma.
- Further multi-center studies with larger sample sizes are recommended, considering factors like diabetes type, population source, and treatment.
- The specific mechanisms underlying this association and the impact of T2DM on renal cancer mortality require further investigation.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Psychoneuroimmunology: Diabetes and Cancer
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications

